Evidence map›Paper›PMID 39300102›Full record

ArticleScientific reports2024

Disulfiram attenuates cell and tissue damage and blood‒brain barrier dysfunction after intracranial haemorrhage by inhibiting the classical pyroptosis pathway.

Chen Xu, Fangchao Jiang, Yuanfu Mao, Wan Wei, Jihe Song, Feihong Jia, Xinshu Du, Di Zhong, Guozhong Li

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chen XuDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Fangchao JiangDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yuanfu MaoDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Wan WeiDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Jihe SongDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Feihong JiaDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Xinshu DuDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Di ZhongDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. dityan@163.com.
Guozhong LiDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. lgzhyd1962@163.com.

Funding

the Heilongjiang Province Key R&D Program JD22C002
6 · The paper itself

Abstract

No single treatment significantly reduces the mortality rate and improves neurological outcomes after intracerebral haemorrhage (ICH). New evidence suggests that pyroptosis-specific proteins are highly expressed in the perihaematomal tissues of patients with ICH and that the disulfiram (DSF) inhibits pyroptosis. An ICH model was established in C57BL/6 mice by intracranial injection of collagenase, after which DSF was used to treat the mice. Cell model of ICH was constructed, and DSF was used to treat the cells. HE, TUNEL, Nissl, FJC and IF staining were performed to evaluate the morphology of brain tissues; Western blotting and ELISA were performed to measure the protein expression of NOD-like receptor protein 3 (NLRP3)/Caspase-1/gasdermin D (GSDMD) classical pyroptosis pathway and Toll-likereceptor4 (TLR4)/nuclear factor-kappaB (NF-κB) inflammatory signaling pathway and blood‒brain barrier-associated factoes, and the wet/dry weight method was used to determine the brain water content. The expression of proteins related to the NLRP3/Caspase-1/GSDMD pathway and the TLR4/NF-κB pathway was upregulated in tissues surrounding the haematoma compared with that in control tissues; Moreover, the expression of the blood-brain barrier structural proteins occludin and zonula occludens-1 (ZO-1) was downregulated, and the expression of Aquaporin Protein-4 (AQP4) and matrix metalloprotein 9 (MMP-9) was upregulated. DSF significantly inhibited these changes, reduced the haematoma volume, decreased the brain water content, reduced neuronal death and degeneration and improved neurological function after ICH. ICH activated the classical pyroptosis pathway and TLR4/NF-κB inflammatory pathway, disruped the expression of blood-brain barrier structural proteins, and exacerbated brain injury and neurological dysfunction. DSF inhibited these changes and exerted the therapeutic effects on pathological changes and dysfunction caused by ICH.

Indexed as

Blood-Brain BarrierDisulfiramMice, Inbred C57BLNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisSignal TransductionToll-Like Receptor 4AnimalsCaspase 1Disease Models, AnimalGasderminsHumansIntracranial HemorrhagesMaleMatrix Metalloproteinase 9Casp1 protein, mouseCaspase 1DisulfiramGasderminsGsdmd protein, mouseMatrix Metalloproteinase 9NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseOccludinPhosphate-Binding ProteinsTjp1 protein, mouseTlr4 protein, mouseToll-Like Receptor 4Zonula Occludens-1 ProteinBlood‒brain barrierDisulfiramGSDMDIntracerebral haemorrhagePyroptosis

Identifiers

PMID39300102
PMCPMC11413208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.